zidovudine has been researched along with kni-727 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Matsumoto, H; Ota, H; Sano, K | 1 |
| Camarasa, MJ; de Castro, S | 1 |
| Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Kumagai, A; Matsumoto, H; Sano, K | 1 |
1 review(s) available for zidovudine and kni-727
| Article | Year |
|---|---|
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Polypharmacology | 2018 |
2 other study(ies) available for zidovudine and kni-727
| Article | Year |
|---|---|
'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
Topics: Anti-HIV Agents; HIV Protease Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Prodrugs; Reverse Transcriptase Inhibitors; Thiazoles; Zidovudine | 2000 |
Design, synthesis, and biological evaluation of anti-HIV double-drugs. conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers.
Topics: Animals; Anti-HIV Agents; Drug Design; Drug Evaluation, Preclinical; HIV Protease Inhibitors; Humans; Prodrugs; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; Zidovudine | 2001 |